» Articles » PMID: 23166340

Age, Academic Performance, and Stimulant Prescribing for ADHD: a Nationwide Cohort Study

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2012 Nov 21
PMID 23166340
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We evaluated whether younger age in class is associated with poorer academic performance and an increased risk of being prescribed stimulants for attention-deficit/hyperactivity disorder (ADHD).

Methods: This was a nationwide population-based cohort study, linking data from national registries of prescribed drugs and standardized scholastic examinations. The study population comprised all children born in 1994-1996 who took standardized tests in Iceland at ages 9 and 12 (n = 11 785). We estimated risks of receiving low test scores (0-10th percentile) and being prescribed stimulants for ADHD. Comparisons were made according to children's relative age in class.

Results: Mean test scores in mathematics and language arts were lowest among the youngest children in the fourth grade, although the gap attenuated in the seventh grade. Compared with the oldest third, those in the youngest third of class had an increased relative risk of receiving a low test score at age 9 for mathematics (1.9; 95% confidence interval [CI] 1.6-2.2) and language arts (1.8; 95% CI 1.6-2.1), whereas at age 12, the relative risk was 1.6 in both subjects. Children in the youngest third of class were 50% more likely (1.5; 95% CI 1.3-1.8) than those in the oldest third to be prescribed stimulants between ages 7 and 14.

Conclusions: Relative age among classmates affects children's academic performance into puberty, as well as their risk of being prescribed stimulants for ADHD. This should be taken into account when evaluating children's performance and behavior in school to prevent unnecessary stimulant treatment.

Citing Articles

Digital Homework Support Program for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Protocol for a Randomized Controlled Trial.

Gollier-Briant F, Ollivier L, Joalland P, Mouchabac S, Leray P, Bonnot O JMIR Res Protoc. 2024; 13:e44553.

PMID: 39571155 PMC: 11621713. DOI: 10.2196/44553.


Systematic review and meta-analysis: relative age in attention-deficit/ hyperactivity disorder and autism spectrum disorder.

Frisira E, Holland J, Sayal K Eur Child Adolesc Psychiatry. 2024; 34(2):381-401.

PMID: 38767699 PMC: 11868292. DOI: 10.1007/s00787-024-02459-x.


Relative age and specific learning disorder diagnoses: A Finnish population-based cohort study.

Arrhenius B, Gyllenberg D, Vuori M, Tiiri E, Lempinen L, Sourander A JCPP Adv. 2023; 1(1):e12001.

PMID: 37431502 PMC: 10242877. DOI: 10.1111/jcv2.12001.


The effect of school-entry age on health is understudied in low- and middle-income countries: A scoping review and future directions for research.

Liao J, Schroder H, Chin E, Bakare M, Moshoeshoe R, Caudillo M SSM Popul Health. 2023; 22:101423.

PMID: 37223750 PMC: 10200977. DOI: 10.1016/j.ssmph.2023.101423.


Difficulties in Managing Children's Learning among Caregivers of Children with Attention-Deficit/Hyperactivity Disorder during the COVID-19 Pandemic in Taiwan: Association with Worsened Behavioral and Emotional Symptoms.

Chen C, Chen J, Lin C, Hsiao R, Tsai C, Yen C Int J Environ Res Public Health. 2022; 19(21).

PMID: 36360603 PMC: 9659146. DOI: 10.3390/ijerph192113722.


References
1.
Zoega H, Furu K, Halldorsson M, Thomsen P, Sourander A, Martikainen J . Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand. 2010; 123(5):360-7. DOI: 10.1111/j.1600-0447.2010.01607.x. View

2.
Steinhausen H . The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder. Acta Psychiatr Scand. 2009; 120(5):392-9. DOI: 10.1111/j.1600-0447.2009.01446.x. View

3.
Biederman J . Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005; 57(11):1215-20. DOI: 10.1016/j.biopsych.2004.10.020. View

4.
Zoega H, Baldursson G, Hrafnkelsson B, Almarsdottir A, Valdimarsdottir U, Halldorsson M . Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol. 2009; 19(6):757-64. DOI: 10.1089/cap.2009.0003. View

5.
Gaub M, Carlson C . Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997; 36(8):1036-45. DOI: 10.1097/00004583-199708000-00011. View